Follow the conference on X #DeprescribingMH
This conference focuses on optimising and improving deprescribing in mental health services as outlined in the NHS England Framework for action for integrated care boards (ICBs) and primary care.
The conference will explore the latest developments and guidance in deprescribing, including practical case studies from various trusts and initiatives. We will look at alternatives to pharmacological interventions, recovery from sleeping tablets and tranquilisers, and deprescribing in older people, followed by a panel discussion with leading experts in these areas.
Join us as we engage with leading experts who will share insights and success stories, as well as the potential future of deprescribing in mental health.
“The prescribing numbers for antidepressants have been consistently trending upwards in recent years. Clinicians treating someone who is taking them should regularly review whether they are still providing benefits or might no longer be needed. They should also inform the patient about the advantages and risks of reducing their dose so that they can take part in the decision-making process. It is important to note that, for many patients, antidepressants are part of a lifesaving treatment programme. Patients should not stop taking antidepressants suddenly and should talk to their doctor beforehand. ”
Dr Adrian James, president of the Royal College of Psychiatrists, January 2023
“Prescribing and deprescribing decisions should be made jointly with the patient; their informed consent needs to be obtained and appropriate information on the risks and benefits of using the medicines given. A shared decision-making approach will help manage patients’ expectations about managing their pain and other symptoms. ”
Optimising personalised care for adults prescribed medicines associated with dependence or withdrawal symptoms: Framework for action for integrated care boards (ICBs) and primary care, January 2023
This conference will enable you to:
Network with colleagues who are working to improve patient cantered care in mental health deprescribing
Learn from outstanding practice in deprescribing from antidepressants
Reflect on lived experience
Understand current statistics in prescription psychotropics and the challenges in implementing deprescribing guidelines in clinical practice
Reflect on national developments and learning
Develop and support your staff to deprescribing effectively
Implement strategies to minimise risks during the deprescribing process
Reflect on the NHS England Framework for action for integrated care boards (ICBs) and primary care
Develop your skills in ensuring prescribing/deprescribing decisions are made jointly with the patient
Explore the evidence from case studies in alternatives to pharmacological interventions and appropriately commissioned services
Understand how new initiatives are supporting deprescribing from long-term antidepressants in Primary Care
Identify key strategies for managing co-morbidity and the reality of living with mental and physical illness
Understand the priority areas for quality improvement for the care of adult with depression
Reflect on the management reducing drug withdrawal symptoms deprescribing in older people
Learn from best practice and success stories in supporting people struggling with benzodiazepines and other Z drugs
Self assess and reflect on your own practice
Supports CPD professional development and acts as revalidation evidence. This course provides 5 Hrs training for CPD subject to peer group approval for revalidation purposes
